phenyl acetate has been researched along with glucagon-like peptide 1 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cuber, JC; Cuche, G; Malbert, CH | 1 |
| Freeland, KR; Wolever, TM | 1 |
| Tarini, J; Wolever, TM | 1 |
| Al-Shurbaji, A; Denison, H; Eriksson, JW; Himmelmann, A; Knutsson, M; Löfgren, L; Mårtensson, G; Nilsson, C; Tornqvist, H | 1 |
| Minoura, H; Negoro, K; Shibasaki, M; Shimaya, A; Shimokawa, T; Tanaka, H; Yoshida, S | 1 |
2 trial(s) available for phenyl acetate and glucagon-like peptide 1
| Article | Year |
|---|---|
The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects.
Topics: Acetates; Adult; Blood Glucose; Butyrates; Colon; Cross-Over Studies; Dietary Fiber; Fatty Acids, Nonesterified; Fatty Acids, Volatile; Female; Fermentation; Ghrelin; Glucagon-Like Peptide 1; Humans; Insulin; Inulin; Male; Postprandial Period; Propionates; Reference Values; Single-Blind Method; Time Factors | 2010 |
Diacylglycerol acyltransferase 1 inhibition with AZD7687 alters lipid handling and hormone secretion in the gut with intolerable side effects: a randomized clinical trial.
Topics: Acetates; Adult; Anti-Obesity Agents; Diabetes Mellitus, Type 2; Diacylglycerol O-Acyltransferase; Diarrhea; Dose-Response Relationship, Drug; Gastric Emptying; Glucagon-Like Peptide 1; Humans; Intestinal Absorption; Male; Middle Aged; Obesity; Peptide YY; Pyrazines; Treatment Outcome; Weight Loss | 2014 |
3 other study(ies) available for phenyl acetate and glucagon-like peptide 1
| Article | Year |
|---|---|
Ileal short-chain fatty acids inhibit gastric motility by a humoral pathway.
Topics: Acetates; Animals; Autonomic Denervation; Fatty Acids, Volatile; Female; Gastric Emptying; Glucagon-Like Peptide 1; Ileum; Peptide YY; Peptides; Pyloric Antrum; Reflex; Swine | 2000 |
Acute effects of intravenous and rectal acetate on glucagon-like peptide-1, peptide YY, ghrelin, adiponectin and tumour necrosis factor-alpha.
Topics: Acetates; Adiponectin; Administration, Rectal; Adult; Blood Glucose; Cross-Over Studies; Female; Ghrelin; Glucagon-Like Peptide 1; Humans; Injections, Intravenous; Insulin; Kinetics; Middle Aged; Patient Selection; Peptide YY; Random Allocation; Sodium Acetate; Tumor Necrosis Factor-alpha | 2010 |
Novel GPR40 agonist AS2575959 exhibits glucose metabolism improvement and synergistic effect with sitagliptin on insulin and incretin secretion.
Topics: Acetates; Animals; Blood Glucose; Dipeptidyl-Peptidase IV Inhibitors; Drug Synergism; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Glycated Hemoglobin; Hypoglycemic Agents; Incretins; Insulin; Insulin Secretion; Male; Mice; Mice, Inbred ICR; Mice, Obese; Pyrazines; Receptors, G-Protein-Coupled; Sitagliptin Phosphate; Spiro Compounds; Triazoles | 2014 |